Education
About Us
Working with TipRanks
Follow Us
Althea Group Holdings Ltd. (AU:AGH)
ASX:AGH
RESEARCH TOOLSreports
AGH Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.05
Previous CloseN/A
Volume191.55K
Average Volume (3M)511.99K
Market Cap
AU$19.74M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$331.00K
Total Debt (Recent Filing)AU$6.54M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding822,575,400
10 Day Avg. Volume345,292
30 Day Avg. Volume511,992
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Althea Group Holdings Ltd. News
PremiumCompany Announcements
Althea Group Holdings Updates Head Office Contact Number
PremiumCompany Announcements
Althea Group Holdings Shifts Focus to THC Beverages for Growth
PremiumCompany Announcements
Althea Group Holdings Shifts Focus to THC-Infused Beverages
PremiumCompany Announcements
Althea Group Holdings Appoints New CFO to Drive Financial Growth
PremiumCompany Announcements
Althea Group Shifts Focus to THC Beverages, Withdraws FY25 Guidance
PremiumCompany Announcements
Althea Group Holdings Announces Change in Substantial Holder Interests
PremiumCompany Announcements
Althea Group’s Director Acquires Significant ShareholdingOptions Prices
Currently, No data available
---
Ownership Overview
7.91% Insiders
―
Mutual Funds
― Other Institutional Investors
92.09% Public Companies and
Individual Investors
AGH FAQ
What was Althea Group Holdings Ltd.’s price range in the past 12 months?
Althea Group Holdings Ltd. lowest share price was AU$0.02 and its highest was AU$0.05 in the past 12 months.
What is Althea Group Holdings Ltd.’s market cap?
Althea Group Holdings Ltd.’s market cap is AU$19.74M.
When is Althea Group Holdings Ltd.’s upcoming earnings report date?
Althea Group Holdings Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 91 days.
How were Althea Group Holdings Ltd.’s earnings last quarter?
Althea Group Holdings Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Althea Group Holdings Ltd. overvalued?
According to Wall Street analysts Althea Group Holdings Ltd.’s price is currently Overvalued.
Does Althea Group Holdings Ltd. pay dividends?
Althea Group Holdings Ltd. does not currently pay dividends.
What is Althea Group Holdings Ltd.’s EPS estimate?
Althea Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Althea Group Holdings Ltd. have?
Althea Group Holdings Ltd. has 822,575,400 shares outstanding.
What happened to Althea Group Holdings Ltd.’s price movement after its last earnings report?
Althea Group Holdings Ltd. reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Althea Group Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:AGH
Althea Group Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:AGH Sentiment 66%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$120.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.11%
12-Months-Change
Fundamentals
Return on Equity
-218.38%
Trailing 12-Months
Asset Growth
-36.02%
Trailing 12-Months
Company Description
Althea Group Holdings Ltd.
Althea Group Holdings Ltd. (AGH) is a diversified global pharmaceutical company specializing in the development and distribution of medical cannabis products. Founded in Australia, AGH operates in both the domestic and international markets, providing a range of medicinal cannabis solutions aimed at improving patient outcomes. The company's core products include high-quality cannabis oils, dried flower, and other innovative formulations designed to meet the needs of patients and healthcare professionals.